DE69312391T2 - Synthetische Lipid-A Clykoconjugate-Antigene und deren Verwendung in Impfstoffen - Google Patents

Synthetische Lipid-A Clykoconjugate-Antigene und deren Verwendung in Impfstoffen

Info

Publication number
DE69312391T2
DE69312391T2 DE69312391T DE69312391T DE69312391T2 DE 69312391 T2 DE69312391 T2 DE 69312391T2 DE 69312391 T DE69312391 T DE 69312391T DE 69312391 T DE69312391 T DE 69312391T DE 69312391 T2 DE69312391 T2 DE 69312391T2
Authority
DE
Germany
Prior art keywords
vaccines
antigens
clycoconjugate
synthetic lipid
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69312391T
Other languages
English (en)
Other versions
DE69312391D1 (de
Inventor
Massimo Porro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE69312391D1 publication Critical patent/DE69312391D1/de
Application granted granted Critical
Publication of DE69312391T2 publication Critical patent/DE69312391T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69312391T 1992-05-07 1993-03-17 Synthetische Lipid-A Clykoconjugate-Antigene und deren Verwendung in Impfstoffen Expired - Fee Related DE69312391T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87940392A 1992-05-07 1992-05-07

Publications (2)

Publication Number Publication Date
DE69312391D1 DE69312391D1 (de) 1997-08-28
DE69312391T2 true DE69312391T2 (de) 1997-12-11

Family

ID=25374087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312391T Expired - Fee Related DE69312391T2 (de) 1992-05-07 1993-03-17 Synthetische Lipid-A Clykoconjugate-Antigene und deren Verwendung in Impfstoffen

Country Status (14)

Country Link
EP (1) EP0570682B1 (de)
JP (1) JPH0641200A (de)
KR (1) KR930023369A (de)
AT (1) ATE155790T1 (de)
AU (1) AU664609B2 (de)
CA (1) CA2095588A1 (de)
DE (1) DE69312391T2 (de)
DK (1) DK0570682T3 (de)
ES (1) ES2104984T3 (de)
FI (1) FI932053A (de)
GR (1) GR3024706T3 (de)
IL (1) IL105605A0 (de)
NO (1) NO180234C (de)
SG (1) SG47582A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008214256A (ja) * 2007-03-02 2008-09-18 Yaizu Suisankagaku Industry Co Ltd 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤
US20110229513A1 (en) * 2008-09-05 2011-09-22 Cox Andrew D LPS Based Vaccines
CN114712383A (zh) * 2016-03-30 2022-07-08 阿尤维斯研究有限公司 新组合物和治疗方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
JPH04507244A (ja) * 1989-07-27 1992-12-17 ユニバックス・バイオロジクス・インコーポレイテッド リピドａ類似体／免疫原性担体コンジュゲートおよびそのワクチンとしての使用

Also Published As

Publication number Publication date
NO931655L (no) 1993-11-08
NO180234C (no) 1997-03-12
GR3024706T3 (en) 1997-12-31
IL105605A0 (en) 1993-09-22
NO180234B (no) 1996-12-02
ATE155790T1 (de) 1997-08-15
SG47582A1 (en) 1998-04-17
AU664609B2 (en) 1995-11-23
NO931655D0 (no) 1993-05-06
KR930023369A (ko) 1993-12-18
DE69312391D1 (de) 1997-08-28
DK0570682T3 (da) 1998-02-16
EP0570682A1 (de) 1993-11-24
CA2095588A1 (en) 1993-11-08
JPH0641200A (ja) 1994-02-15
AU3841993A (en) 1993-11-11
ES2104984T3 (es) 1997-10-16
FI932053A (fi) 1993-11-08
FI932053A0 (fi) 1993-05-06
EP0570682B1 (de) 1997-07-23

Similar Documents

Publication Publication Date Title
ATE184274T1 (de) N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
EG19999A (en) Process for preparing of piperazinyl - and piperidinyl cyclohexanols
DK0445578T3 (da) Formlegemer
DE69116305T2 (de) Verfahren zur Herstellung von Trehalulose und Isomaltulose
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
HU9401511D0 (en) Vaccine against streptococcus suls infection
ES2093099T3 (es) Preparacion de piperidinas sustituidas.
DE69312391T2 (de) Synthetische Lipid-A Clykoconjugate-Antigene und deren Verwendung in Impfstoffen
GR81181B (en) Substituted o-acyl-glycosylamide, method for the preparation thereof
ATE108557T1 (de) Extraktionsverfahren.
AU6873587A (en) Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
DE69111401D1 (de) Tert-Butyloxycarbonyl-L-Tyrosyl-Peptidoglycanmonomer und deren 125 I-markiertes Derivat, deren Herstellung und Verwendung.
EP0292806A3 (en) Substituted vinyl cephalosporins, process for their preparation and their use as medicines
FI911126A0 (fi) Organokupraattimenetelmä kefprotsilin valmistamiseksi
ATE58379T1 (de) Verfahren zur herstellung von alkylierten hydroxylgruppenfreien glycosylfluoriden.
FR2659650B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphnylene diamines.
IT1240742B (it) Stabilizzanti per polimeri a basso grado di polverosita'
FR2557457B1 (fr) Procede de preparation de l'antigene tuberculinique l.
IT8653055V0 (it) Sistema di schiusura per vetrate pieghevoli senza l ausilio di meccanismi di chiusura tradizionali
IT9021155A0 (it) "procedimento di desolforazione microbiologica del carbone"
IT1261660B (it) Composti dotati di caratteristiche fotocromatiche in presenza di ossigeno e metodi per la loro preparazione
IT1228141B (it) Metodo per la produzione concimi composti umificanti bilanciati di pollina e l'eliminazione degli odori per combustione con il recupero del calore

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee